Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Chlorthalidone to Reduce Urinary Calcium Excretion in Adolescents/Yount Adult With Type 1 Diabetes

NCT03325114 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

NCT NCT03325114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03325114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Chlorthalidone to Reduce Urinary Calcium Excretion in Adolescents/Yount Adult With Type 1 Diabetes
Lead sponsor
University of Rochester
Phase
Phase 2
Overall status
Terminated
Start date
June 28, 2019
Completion date
June 1, 2020
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypercalciuria, type 1 diabetes mellitus